All Type of News


Biologic & drug-related licenses to be created in 2019

If licenses related to medicine are created next year, they are expected to be implemented in the 2nd half of 2019. Certification Analysis and Planning Team Manager Seok-Geun Jang at the Human Resources Development S...

2-way competition over KPDA presidency between Meng-Ho Lim and Sun-Hye Cho

3 months ahead of the election for the president of the Korea Pharmaceutical Distribution Association(KPDA) at its general meeting on February next year, there is a high chance to the election to be completed by 2 str...

MFDS with a high chance of personnel reshuffle for director-level officers and local government chiefs

In order to stabilize the ministry’s organization and avoid confusion, Minister Young-Jin Ryu of Food and Drug Safety is expected to carry out a personnel reshuffle on director-level officers and local government chie...

Humira takes over ‘uveitis’ as well with versatility

‘Humira(generic name: adalimumab),’ the most well-known TNF(tumor necrosis factor)-α inhibitor and a chronic immune disorder treatment having 14 Korean indications in Korea, has attracted attention of the industry as ...

Kwang Dong Pharmaceutical signs contract sales agreement of Jeju Samdasoo

Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 9th that it signed a contract sales agreement of Jeju Samdasoo retail products with the Jeju Province Development Co.(President Kyung-Soo Oh) at Sheraton S...

Big5 pharmas, Yuhan and Daewoong top in sales and profitability respectively

While the ‘Big5’ pharmaceutical companies’ business performance is evaluated excellent this year, Yuan Corporation and Daewoong Pharmaceutical was analyzed to have a remarkable business performance. Yakup Shinmoon(ww...

Pharmaceutical companies’ poor quality control on their imported medicines

Multinational pharmaceutical companies were criticized for poorly managing their imported medicines. According to the Ministry of Food and Drug Safety(MFDS), there has been an increasing number of multinational pharm...

Samsung Bioepis acquires product approval of ‘Samfenet,’ Herceptin biosimilar

‘SB3(product name: Samfenet, generic name: trastuzumab),’ a Samsung Bioepis’ cancer therapy biosimilar, acquire product approval from the Ministry of Food and Drug Safety on the 8th. Samfenet is a biosimilar of ‘Herc...

Dongwon I Pharm proves efficiency of distribution with patent

A pharmaceutical distribution company has drawn interests as showing a direction for efficiency of distribution with a patent. Dongwon I Pharm is expected to bring a new era in the distribution industry as acquiring ...

Standigm reveals novel drug discovering services using new AI technology

A novel drug discovering company based on artificial intelligence ‘Standigm(CEO Jin-Han Kim)’ announced the company selected as the next-generation pharmaceutical and biotechnology company at the ‘23th Bio-Europe,’ an...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.